Search research articles
Contact Us
Filters
Showing results (661-670 of 778) with videos related to
Page
of 78
Sort By:
The Annals of Thoracic Surgery
|
June 25, 2023
Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial
Alexandra L Potter, Christina L Costantino, Raiya A Suliman, et al.
Biochemical and Biophysical Research Communications
|
May 28, 2003
Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates
Y T Ho, A Purohit, N Vicker, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 20, 2023
Segmentectomy versus lobectomy in the United States: Outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers
Alexandra L Potter, Joshua Kim, Meghan L McCarthy, et al.
Journal of the American Chemical Society
|
June 16, 2005
Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca(2+)-mobilizing second messenger. Structure--activity relationship of the N1-ribose moiety
Takashi Kudoh, Masayoshi Fukuoka, Satoshi Ichikawa, et al.
British Journal of Cancer
|
November 21, 2007
The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers
S P Newman, P A Foster, Y T Ho, et al.
The Biochemical Journal
|
June 5, 2009
8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist
Tanja Kirchberger, Christelle Moreau, Gerd K Wagner, et al.
Annals of Surgery
|
June 19, 2023
Efficacy and Safety of Supraclavicular Thoracic Outlet Decompression
Nikhil Panda, Jacob Hurd, James Madsen, et al.
Molecular and Cellular Endocrinology
|
September 13, 2008
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3
Joanna M Day, Helena J Tutill, Paul A Foster, et al.
Bulletin of the World Health Organization
|
September 2, 2024
Drug-resistant tuberculosis treatments, the case for a phase III platform trial
Tom A Yates, Samara Barnes, Martin Dedicoat, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Wedge Resection versus Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors ≤8 mm
Arian Mansur, Zain Saleem, Jorind Beqari, et al.
Page
of 78
Search research articles
Search
Showing results (661-670 of 778) with videos related to
Sort By:
Page
of 78
The Annals of Thoracic Surgery
|
June 25, 2023
Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial
Alexandra L Potter, Christina L Costantino, Raiya A Suliman, et al.
Biochemical and Biophysical Research Communications
|
May 28, 2003
Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates
Y T Ho, A Purohit, N Vicker, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 20, 2023
Segmentectomy versus lobectomy in the United States: Outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers
Alexandra L Potter, Joshua Kim, Meghan L McCarthy, et al.
Journal of the American Chemical Society
|
June 16, 2005
Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca(2+)-mobilizing second messenger. Structure--activity relationship of the N1-ribose moiety
Takashi Kudoh, Masayoshi Fukuoka, Satoshi Ichikawa, et al.
British Journal of Cancer
|
November 21, 2007
The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers
S P Newman, P A Foster, Y T Ho, et al.
The Biochemical Journal
|
June 5, 2009
8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist
Tanja Kirchberger, Christelle Moreau, Gerd K Wagner, et al.
Annals of Surgery
|
June 19, 2023
Efficacy and Safety of Supraclavicular Thoracic Outlet Decompression
Nikhil Panda, Jacob Hurd, James Madsen, et al.
Molecular and Cellular Endocrinology
|
September 13, 2008
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3
Joanna M Day, Helena J Tutill, Paul A Foster, et al.
Bulletin of the World Health Organization
|
September 2, 2024
Drug-resistant tuberculosis treatments, the case for a phase III platform trial
Tom A Yates, Samara Barnes, Martin Dedicoat, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Wedge Resection versus Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors ≤8 mm
Arian Mansur, Zain Saleem, Jorind Beqari, et al.
Page
of 78